Want to see MD full AI Analyst Report?
MD Stock Chart & Stats
$26.95
-$0.12(-0.46%)
At close: 4:00 PM EDT
$26.95
-$0.12(-0.46%)
Day’s Range― - ―
52-Week Range$16.82 - $28.29
Previous Close$26.14
Volume754.70K
Average Volume (3M)709.35K
Market Cap
$2.28B
Enterprise Value$2.28B
Total Cash (Recent Filing)$404.20M
Total Debt (Recent Filing)$619.96M
Price to Earnings (P/E)13.3
Beta0.61
Next Earnings
Oct 29, 2026EPS Estimate
0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.11
Shares Outstanding81,253,270
10 Day Avg. Volume664,368
30 Day Avg. Volume709,348
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)2.11
Price to Sales (P/S)0.95
P/FCF Ratio7.22
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit4.50
Enterprise Value/Ebitda8.53
Forecast
1Y Price Target
$27.40Price Target Upside1.67% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)2.35
Revenue Forecast (FY)$1.96B
Bulls Say, Bears Say
Bulls Say
Profitability RecoveryThe return to positive operating and net profitability materially strengthens the business after prior losses. If margins remain near current levels, Pediatrix can fund operations internally, support investment in care delivery, and retain greater resilience through reimbursement or volume pressure.
Cash GenerationStrong conversion of earnings into free cash flow supports debt service, reinvestment, and shareholder returns without relying solely on external financing. Although growth has been uneven, the current cash-generative model provides an important foundation for maintaining financial flexibility.
National Clinical FootprintA broad, specialized footprint across women's and children's care gives Pediatrix an established platform for expanding services and telemedicine-linked offerings. Scale can improve hospital coverage opportunities, clinician utilization, and the ability to replicate growth initiatives across multiple markets.
Bears Say
Volume DeclinesPersistent softness in patient volumes can constrain revenue growth because Pediatrix primarily earns fees when affiliated clinicians deliver care. Lower NICU utilization and uncertain birth-rate trends may also reduce operating leverage, making margin improvement more dependent on pricing and cost control.
Easing Collections TailwindThe expected fading of RCM-related pricing support creates a less favorable base for subsequent revenue growth. Without the same collections benefit, Pediatrix may need continued payer-mix improvement, higher acuity, or operational expansion to offset slower pricing momentum and sustain recent performance.
Expense PressureHigher practice-level compensation and elevated G&A can absorb part of the profitability recovery if they persist. A cost base rising faster than underlying volume would limit operating leverage, pressure margins, and leave less cash available for expansion, debt reduction, or repurchases.
Pediatrix Medical Group News
MD FAQ
What was Pediatrix Medical Group’s price range in the past 12 months?
Pediatrix Medical Group lowest stock price was $16.82 and its highest was $28.29 in the past 12 months.
What is Pediatrix Medical Group’s market cap?
Pediatrix Medical Group’s market cap is $2.28B.
When is Pediatrix Medical Group’s upcoming earnings report date?
Pediatrix Medical Group’s upcoming earnings report date is Oct 29, 2026 which is in 8 days.
How were Pediatrix Medical Group’s earnings last quarter?
Pediatrix Medical Group released its earnings results on Aug 04, 2026. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.591 by $0.039.
Is Pediatrix Medical Group overvalued?
According to Wall Street analysts Pediatrix Medical Group’s price is currently Undervalued.
Does Pediatrix Medical Group pay dividends?
Pediatrix Medical Group does not currently pay dividends.
What is Pediatrix Medical Group’s EPS estimate?
Pediatrix Medical Group’s EPS estimate is 0.65.
How many shares outstanding does Pediatrix Medical Group have?
Pediatrix Medical Group has 81,253,270 shares outstanding.
What happened to Pediatrix Medical Group’s price movement after its last earnings report?
Pediatrix Medical Group reported an EPS of $0.63 in its last earnings report, beating expectations of $0.591. Following the earnings report the stock price went down -5.867%.
Which hedge fund is a major shareholder of Pediatrix Medical Group?
Currently, no hedge funds are holding shares in MD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pediatrix Medical Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$27.40 (1.67% Upside)
$27.40 (1.67% Upside)
Blogger Sentiment
Neutral
MD Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 169.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 15.9%
Last 30 Days ▲ 15.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.35%
12-Months-Change
Fundamentals
Return on Equity
19.89%
Trailing 12-Months
Asset Growth
1.34%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Pediatrix Medical Group
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
MD Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented several meaningful positives: solid adjusted EBITDA ($76M), reaffirmed full-year guidance ($280M–$300M), improved payer mix and pricing, a strong balance sheet with $289M cash and low leverage (~1x), ongoing share buybacks, and strategic expansion into telehybrid services leveraging a large national footprint. Offsetting these positives are modest volume declines (same-unit volumes down 2%, NICU days down 3%), lower operating cash flow YoY, higher practice-level SW&B and G&A (including executive transition costs), and management’s expectation that the favorable RCM collections tailwind will ease in H2 2026. Overall, the call emphasized financial strength, disciplined capital allocation and strategic growth initiatives while acknowledging near-term volume and expense headwinds.View all MD earnings summariesMD Stock 12 Month Forecast
Average Price Target
$27.40
▲(1.67% Upside)
Technical Analysis
Community Health
―
HCA Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ardent Health Partners, Inc.
―
Ownership Overview
1.56% Insiders
36.36% Mutual Funds
3.50% Other Institutional Investors
24.22% Public Companies and
Individual Investors